Should I wait until the amitriptyline taper is finished before starting bupropion (Wellbutrin XL) 150 mg, given my anxiety and tachycardia, and then add buspirone and hydroxyzine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Wait to Start Bupropion Until Amitriptyline Taper is Complete

Given the current side effects of increased anxiety and tachycardia, you should delay starting Wellbutrin XL 150 mg until the amitriptyline taper is finished, then initiate buspirone and hydroxyzine for anxiety management before considering bupropion.

Rationale for Delaying Bupropion

Bupropion is contraindicated in agitated patients and is known to be "activating" with potential to worsen anxiety, particularly during initial treatment 1. The FDA label explicitly states that bupropion "should not be used in agitated patients" 1. Your patient is already experiencing increased anxiety and tachycardia—both predictable adverse effects of bupropion that suggest poor tolerability in this clinical context.

Why the Current Symptoms Matter

The combination of amitriptyline withdrawal and bupropion initiation creates a perfect storm:

  • Amitriptyline withdrawal can cause anxiety, irritability, and agitation as part of discontinuation syndrome 2
  • Bupropion's activating properties include anxiety, insomnia, and tachycardia as common side effects 1, 3
  • Tricyclic antidepressants like amitriptyline can cause tachycardia themselves 1, and the patient may still have residual drug effects during the taper

Starting bupropion during an amitriptyline taper compounds these risks unnecessarily.

Recommended Treatment Algorithm

Step 1: Complete Amitriptyline Taper (Next 1.5 Weeks)

  • Continue the current taper schedule
  • Monitor for withdrawal symptoms: anxiety, irritability, insomnia, dizziness 2
  • Discontinue over 10-14 days to limit withdrawal symptoms 1

Step 2: Initiate Anxiety Management Immediately

Start buspirone and hydroxyzine now (during the amitriptyline taper):

  • Buspirone: Start 5 mg twice daily, can increase to maximum 20 mg three times daily 1

    • Takes 2-4 weeks to become effective 1
    • No interaction concerns with amitriptyline—studies show no significant pharmacokinetic changes when combined 4
    • Useful for mild-to-moderate anxiety 1
  • Hydroxyzine: 12.5 mg morning and midday, 25 mg evening (standard dosing) 5

    • Provides immediate anxiolytic effect while buspirone reaches therapeutic levels
    • Superior to placebo for generalized anxiety 5
    • Can help with insomnia if dosed at bedtime

Step 3: Reassess After Amitriptyline Washout (2 Weeks Post-Taper)

Wait at least 1-2 weeks after completing the amitriptyline taper before introducing bupropion. This allows:

  • Full clearance of amitriptyline and its active metabolites
  • Stabilization on buspirone/hydroxyzine
  • Assessment of baseline anxiety without confounding withdrawal effects

Step 4: Consider Bupropion Only If Anxiety is Controlled

If anxiety remains problematic after 2-4 weeks on buspirone/hydroxyzine, do NOT start bupropion. Instead, consider:

  • An SSRI (sertraline, escitalopram) which can address both depression and anxiety 2
  • Increasing buspirone dose if only partially effective
  • Continuing hydroxyzine as needed for breakthrough anxiety

If anxiety is well-controlled and depression symptoms persist:

  • Start bupropion XL at 150 mg once daily in the morning 3
  • Monitor closely for return of anxiety or tachycardia
  • Can increase to 300 mg after 4 days if tolerated 3
  • Give second dose before 3 PM to minimize insomnia 1

Critical Safety Considerations

Drug Interactions

  • No significant interaction between buspirone and amitriptyline 4—safe to start buspirone during the taper
  • Bupropion can interact with multiple medications through CYP2D6 metabolism 2
  • Avoid MAOIs within 14 days of bupropion 3

Monitoring Parameters

  • Heart rate and blood pressure: Both bupropion and amitriptyline can cause tachycardia 1
  • Anxiety symptoms: Use standardized scales to track objectively
  • Sleep quality: Bupropion commonly causes insomnia 1, 3
  • Seizure risk: Bupropion lowers seizure threshold; avoid in patients with seizure disorders 3

Common Pitfalls to Avoid

  1. Starting bupropion too early during the amitriptyline taper—this amplifies anxiety and cardiovascular side effects
  2. Assuming all antidepressants are interchangeable for anxiety—bupropion is specifically NOT recommended for anxious patients 1
  3. Waiting for buspirone to work before starting it—it takes 2-4 weeks to reach full effect 1, so start it immediately
  4. Ignoring the tachycardia—this is a red flag that the patient may not tolerate bupropion well
  5. Not using hydroxyzine for immediate relief—buspirone alone won't provide rapid anxiety control

Why Not Just Push Through with Bupropion?

Recent evidence suggests bupropion's role in anxiety is mixed at best 6. While some studies show it may reduce anxiety in depressed patients with mild-to-moderate anxiety, its "stimulating properties can also provoke anxiety, particularly at higher doses" 6. The 2025 review concludes that "a cautious approach is recommended" with lower starting doses and monitoring for anxiogenic symptoms 6.

Your patient is already experiencing the exact side effects that predict poor bupropion tolerance. Continuing this course risks:

  • Worsening anxiety requiring additional interventions
  • Treatment discontinuation and loss of therapeutic momentum
  • Cardiovascular complications from sustained tachycardia
  • Patient distress and reduced medication adherence

The evidence-based approach is clear: stabilize anxiety first with buspirone and hydroxyzine, complete the amitriptyline taper, then reassess whether bupropion is even appropriate for this patient.

Related Questions

For a patient taking amitriptyline 10 mg nightly and bupropion hydrochloride extended‑release 150 mg daily who still experiences panic attacks, can the doses be increased?
In a patient with PTSD who is taking escitalopram 20 mg and has persistent worry and self‑doubt, would adding bupropion be helpful?
Is it safe to take Wellbutrin (bupropion) and amitriptyline together?
How should the medication regimen (buspirone 15 mg three times daily, fluoxetine 20 mg each morning, bupropion extended‑release 450 mg each morning with food, hydroxyzine 10 mg three times daily as needed, and lurasidone 40 mg each evening with at least 350 kcal) be adjusted for an adult male with social anxiety disorder, schizoid personality disorder, and chronic insomnia (taking up to two hours to fall asleep)?
In a 23-year-old male with anxiety and depression who smokes and wishes to quit, is bupropion (Wellbutrin) an appropriate treatment choice?
How long before or after a meal should buspirone be taken when taken on an empty stomach?
Can topical erythromycin be safely combined with benzoyl peroxide in a patient without known allergies?
Why is graded exercise therapy contraindicated in patients with post‑exertional malaise (PEM)?
How is urinary hippurate measured and interpreted, and what clinical conditions are associated with low or high levels?
What is the safest ADHD medication for a breastfeeding mother?
What is an appropriate taper schedule for a patient taking 15 mg of diazepam (Valium) daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.